GFM
ALT icon

GF Fund Management’s Altimmune ALT Stock Holding History

GF Fund Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7K Buy
3,844
+1,513
+65% +$4.52K ﹤0.01% 524
2026
Q1 		$7.18K Buy
2,331
+282
+14% +$1.2K ﹤0.01% 585
2025
Q4 		$7.4K Buy
2,049
+150
+8% +$654 ﹤0.01% 603
2025
Q3 		$7.16K Buy
1,899
+78
+4% +$301 ﹤0.01% 581
2025
Q2 		$7.05K Hold
1,821
– – ﹤0.01% 602
2025
Q1 		$9.11K Buy
1,821
+328
+22% +$2.08K ﹤0.01% 577
2024
Q4 		$10.8K Buy
+1,493
New +$11.4K ﹤0.01% 531

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's ALT Position: Q2 2026 in Review

GF Fund Management increased its Altimmune (ALT) stake by 65% in Q2 2026, buying an estimated $4.52K and bringing the position to 3,844 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

GF Fund Management first reported a position in ALT in Q4 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • GF Fund Management held 3,844 shares of Altimmune worth $11.7K as of Q2 2026.
  • GF Fund Management bought 1,513 Altimmune shares in Q2 2026, an estimated $4.52K.
  • Altimmune made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #524 holding.
  • GF Fund Management first reported a position in Altimmune in Q4 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.